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ABSTRACT:
Transcranial direct current stimulation (tDCS) is one type of neuromodulation, which is an emerging technology that 
holds promise for the future studies on therapeutic and diagnosis applications in treatment of neurological and 
psychiatric diseases. Epilepsy is one of the commonest neurological disorders, caused by an enhanced cortical 
excitability favoring paroxysmal neuronal discharge. Cathodaldirect current stimulation (ctDCS) is a low-cost non-
invasive portable neuro-stimulatory technique which can transiently decrease cortical excitability in humans. This 
was invasively demonstrated to reduce epileptiform discharges in animals.
INTRODUCTION:
Epilepsy affects approximately 50 million people 
worldwide, and 80% of them live in the developing 
world [1, 2]. Epilepsy is a chronic disorder which not 
only affects the patient but also the entire family. An 
individual is diagnosed to have epilepsy if they have 
two or more unprovoked seizures occurring greater 
than 24 hours apart. Seizures are casued by abnormal 
electrical activity in the brain and can present in a 
variety of forms like tonic-clonic activity of one limb or 
entire body, staring, eye blinking, sudden jerks, sudden 
loss of tone leading to falls. They can also present as 
an abnormal sensation perceived by the patient. 
Patient can have preserved awareness, altered 
awareness or even loss of consciousness during a 
seizure. They are usually brief lasting one to two 
minutes but some seizures can be prolonged. If the 
seizure lasts more than ﬁve minutes, it is considered as 
status epilepticus.During some seizures patients can 
have bowel or bladder incontinence. Some individuals 
continue to have frequent seizures despite optimal 
treatment with anti-seizure drugs. However, more than 
70 percent of patients who are treated achieve long-
term remission or freedom from seizures, normally 
within 5 years of diagnosis [2]. 
Approximately 60% of patients with epilepsy have 
some form of focal epilepsy, and 35% of this cohort 
have an unsatisfactory response to anticonvulsant 
medications (AEDs) [3]. Surgical therapy for 
intractable neocortical epilepsy (NE) remains 
suboptimal and may produce neurologic deﬁcits not 
predicted from pre-surgical evaluation—an especially 
serious problem in children [4, 5]. Although pre-
surgical imaging and electrophysiologic localization of 
the epileptic focus continue to improve, up to 80% of 
resections for non–temporal lobe epilepsy yield 
less than excellent outcomes [6]. The relatively 
disappointing results with present surgical techniques 
have led clinical study epileptologists to explore other 
approaches to treating focal seizures, including 
external electrical ﬁelds, local cortical stimulation with 
implanted electrodes, and microinjection of AEDs [5-
7].
Available pharmacological strategies for seizure relief 
in patients with neocortical epilepsy can be ineffective, 
and are associated with prominent side effects such as 
psychological and behavioral changes. Up to 35%of 
patients with neocortical epilepsy experience drug-
resistance. Furthermore, precise localization of the 
seizure focus for surgical resection is often difﬁcult. A 
particular challenge in the evaluation of intractable 
neocortical epilepsy patients is that in about 30% of 
extra-temporal epilepsy cases, brain MRI does not 
identify a lesion[8].Therefore, a non-pharmacologic, 
non-surgical method to treat neocortical epilepsy with 
limited side effects, either in the hospital or home 
setting, remains an unmet medical need.
Consequences of Epilepsy
A variety of treatment modalities are available in the 
form of drugs, Ketogenic diet, Vagus nerve stimulation 
(VNS), Responsiveneurostimulation (RNS) and 
epilepsy surgery. These modalities enable the majority 
of people with epilepsy (PWE) to control their seizures, 
but in about 30-40% seizures persist inspite of different 
treatment modalities [3]. In many countries, this 
disorder is still shrouded in secrecy and patients prefer 
not to reveal or discuss their condition [4]. 
Understanding the unique and complex impact of 
epilepsy on a person's quality of life (QOL) is also 
increasinglyrecognized as an important component of 
clinical care [5], 
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depends on an accurate diagnosis, making sure that a 
person has epilepsy and knowing what kind is a critical 
ﬁrst step. The diagnosis of epilepsy requires a 
thorough history about the semiology of the event and 
is aided by electroencephalography (EEG). 
EEG has an important role in the diagnosis and 
classiﬁcation of epilepsy. It can also provide 
information for predicting the response to anti-seizure 
drugs and to identify the surgically remediable 
epilepsies.It can give a lot of information about where 
the seizure is originating and how it is propagating in 
the brain.
EEG is an important test for diagnosing epilepsy 
because it records the electrical activity of the brain. It 
is safe and painless. The abnormal waveforms include 
spikes, sharp waves, and spike-and-wave discharges. 
Spikes, sharp waves along with slow waves in a 
speciﬁc area of the brain, such as the left temporal 
lobe, indicate that focal seizures might possibly come 
from that area. Primary generalized epilepsy, on the 
other hand, is suggested by spike-and-wave 
discharges that are widely spread over both 
hemispheres of the brain, especially if they begin in 
both hemispheres at the same time. 
Unfortunately, EEG, although is the principal 
diagnostic test for epilepsy diagnosis, is a passive 
measure of cortical activity, and epileptiform 
discharges are usually sporadic events. Consequently, 
the sensitivity of a single EEG is only 29-55% [18-21], 
and 8% of patients will never have interictal discharges 
[22,23].  I would make sure these references are 
accurate. 
This turns out to be especially challenging when 
bearing in mind epilepsy mimics such as psychogenic 
non-epileptic seizures (PNES), cardiogenic syncope, 
breath holding spells, stereotypies and recurrent 
dystonias/ t remors.  PNES are caused by a 
psychopathological  process and consist  of 
paroxysmal behavioral changes that resemble an 
epileptic seizure but are not associated with 
electrophysiological epileptic changes. They and are 
primarily diagnosed by history and video-EEG. 
Moreover, interictal discharges are seen in up to 12% 
of patients without epilepsy [24,25].Therefore, in some 
cases, an EEG may be carried out while you are asleep 
(sleep EEG) or you may be given a small, portable 
EEG recording device to monitor your brain activity 
over 24 hours (ambulatory EEG).
Activating procedures like photic stimulation, 
hyperventilation and sleep deprivation are used to 
activate both interictal discharges and seizures. Photic 
simulation is useful for activation of generalized 
epileptiform discharges Hyperventilation is particularly 
useful for primary generalized epilepsies; however, it 
can also activate focal epileptiform discharges in up to 
10% in partial epilepsies [27]. Several studies have 
documented that sleep deprivation can increase the 
chance of detecting epileptiform discharges in both 
partial and generalized epilepsies [26]. This is mainly 
and research in this area will identify factors affecting 
quality of life QOL and may lead to strategies that 
improve the management of epilepsy. 
Patients with epilepsy diagnosed in childhood could 
have many schooling hours disrupted, if the frequency 
of seizures were high and this could lead to low 
educat ional  achievement and thus a lower 
employability potential. Occupational related stress 
with assignment deadlines and criticisms by 
supervisors can be stressful enough to trigger seizures 
[7]. Moreover, seizure itself sometime causes 
accidentsand injuries thus preventing sufferers from 
driving and depriving them from many types of 
employment opportunities. Employers usually do not 
give jobs to persons with epilepsy if they are 
experiencing seizures that interfere with job 
performance [8].
Nonetheless, a vast majority of individuals with 
epilepsy in many resource-poor regions do not receive 
treatment [9, 10]. Seizure remission is possible with 
appropriate use of anti-seizure drugs. Epileptic 
patients who were treated withanti-seizure drugs had 
signiﬁcantly better QOL than the untreated people [10]. 
Monotherapy has been recognized to be able to 
control seizures adequately in about 50% of patients 
with epilepsy and polytherapy is only necessary in the 
minority of people with more severe seizures.
Untreated epilepsy is a critical public health issue, as 
people with untreated epilepsy face potentially 
devastating social consequences and poor health 
outcomes. Due to stigma, many persons with epilepsy 
have lower employment and education levels and 
lower socioeconomic status. For example, children 
with epilepsy who have a seizure at school may be 
rejected, while adults may be barred from marriage or 
employment [11-14]. Psychiatric diseases such as 
depression and mood disorders have been reported to 
be common among PWE and are important 
determinants of QOL [15,16].
People with uncontrolled epilepsy have a fear of next 
seizure and may take precautions and impose 
restrictions to avoid of having seizures at inappropriate 
times, public places or social events.
Therefore, the management of epilepsy should be 
aimed at controlling seizures and improving patient's 
community life. Public educational programs should be 
conducted in order to raise awareness of the general 
public regarding the existence of effective therapy and 
eliminate the stigma of epilepsy.
DIAGNOSIS
Epilepsy is considered as fourth most prominent 
neurological disorder in the world that can affect 
people of all age groups. Exactly knowing if a person is 
having an epileptic seizure and diagnosing the type of 
seizure or epilepsy syndrome can sometime be 
difﬁcult. And, since seizures rarely happen in a doctor's 
ofﬁce, the information given to the doctor and other 
health care professionals by you or other witnesses is 
extremely important. Since the treatment of seizures 
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making it optimal for blinding subjects (in sham-
controlled studies) by switching it off after the initial 
sensory experience. A previous study demonstrated 
that current densities 25 mA/cm2 did not damage brain 
tissue and the protocols where 1-2 mA current is 
administered fall within these limits [22]. Previous 
studies have argued that in spite of a fraction of the 
direct current being shunted through the scalp, tDCS 
carries enough currents to the underlying cortex, 
sufﬁcient for neuronal excitability shifts [23]. Another 
study has also reported change in measures of 
cerebral blood ﬂow in brain regions that are subjected 
to transcranial anodal direct current thereby proving 
that transcranially administered direct currents can 
affect tissue excitability as well as regional blood ﬂow 
as an indirect indicator of change in regional tissue 
excitability [24]. 
The impor tant  proper t ies  that  make tDCS 
advantageous over other non-invasive brain 
stimulation methods include its ease of use, its large 
electrode size allowing inﬂuence over a larger neural 
network,  a sham mode al lowing control led 
experiments and randomized controlled clinical trials, 
and its portability making it possible to apply 
s t i m u l a t i o n  w h i l e  t h e  p a t i e n t  r e c e i v e s 
occupational/physical therapy. However, tDCS is 
limited because of its poor temporal resolution and 
anatomical localization. In addition, inter-individual 
variation in conductivity due to differences in scalp, 
hair, and bone composition can hamper the current 
that is transmitted to the brain. Moreover, single 
sessions and multi-day sessions have been done and 
found to be safe [25]. tDCS is being used in the 
epilepsy in different parts of the world.
Most of the studies use cathadoltDCS in 1 mA [21-25]. 
Most of the studies shows improvement in outcome 
(e.g. decrease the epileptic discharge in active 
groups). There is a defect in sample size, and we think 
we should do multi-research in larger sample size due 
to the huge improvement (e.g. Assenza G. 2014, only 
two subjects and show huge improvement which is not 
applicable. In general, tDCS is a good additional 
treatment to epilepsy + medical therapy which is the 
essential treatment until now. 
ECONOMIC EFFECTS OF EPILEPSY
Economically, epilepsy has a huge effect, with almost 
5% of the medical costs of industrialized countries 
given to the disease. Although in real terms morbidity is 
relatively low, the long-term impairments left behind 
are hugely detrimental both in terms of hospital and 
other care sector costs. In the past, the greatest 
prevalence of epilepsy has been in the developed 
countries, but a change in this pattern may be 
expected as more and more countries adopt a more 
Westernized way of life. The overall rate of epilepsy 
incidence in low and middle income countries exceed 
that than of high-income countries, by about 20%. 
due to the effect of sleep deprivation and not the sleep 
per se. Activating procedures can increase the yield of 
detecting interictal epileptiform discharges. 
Thus, EEG can neither rule in nor rule out the diagnosis 
in some situations. But still EEG is one of the most 
important tools for diagnosis of epilepsy. It helps in 
easy monitoring as well as proper management of 
neurological disorders. However, the visual perception 
of this complicated waveform analysis is not without 
difference of opinions and demands highly skilled 
interpreters for disease detection and diagnosis. 
Hence, an automatic detection and monitoring 
approach is desired in future perspectives. If 
parameters and features of EEG signals are extracted 
properly, then it can add great value in diagnosis 
process and patients can be saved from severe harms 
caused by sudden seizure attacks [29]. Accordingly, 
epileptic cases frequently experience deferrals in 
diagnosis and commencement of appropriate 
management. On the other hand, normal physiological 
discharges can be interpreted as epileptiform and the 
patient is unnecessarily started on a seizure 
medication. 
EPILEPSY PREVALENCE:
In 2004, the world health organization (WHO) 
estimated that nearly 80% of the burden of epilepsy 
worldwide is borne by the resource-poor countries. In 
developed countries, the lifetime prevalence rate for 
epilepsy ranges from 3.5 to 10.7 per 1,000 person-
years, and the incidence rate ranges from 24 to 53 per 
100,000 person-years [18]. In recent systematic 
reviews, the lifetime prevalence rates for active 
epilepsy varied from 1.5 to 14 per 1,000 person-years 
in Asia, from 5.1 to 57.0 per 1,000 person-years in Latin 
America, and from 5.2 to 74.4 per 1,000 person-years 
in sub-Saharan Africa [19]. In developing countries, 
this ﬁgure is often close to twice as high due to the 
higher risk of experiencing conditions that can lead to 
permanent brain damage. 
T R A N S C R A N I A L  D I R E C T  C U R R E N T 
STIMULATION (tDCS)
A constant current stimulator and surface electrodes 
soaked in normal saline are required for tDCS. The 
former is the source of steady ﬂow of 0-4 mA direct 
current and it continually monitors the resistance in the 
system. Saline soaked electrodes based onto the 
scalp over desired areas [(e.g. the left or right 
precentral gyrus region (corresponding to C3 or C4 of 
the International 10-20 EEG system)] make terminal 
relaying currents across the scalp and through the 
underlying brain tissue. tDCS is a noninvasive brain 
stimulation technique that induces polarity-dependent 
(anodal electrode increase excitability and cathode 
decrease excitability) alterations of cortical excitability.
Once turned on, the constant current stimulator 
generates a transient tingling sensation under the 
electrode which disappears in 30 sec to 1min thereby
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CONCLUSIONS
Epilepsy is one of the leading causes of death and 
neurological disability in adults, inﬂicting a heavy 
burden on affected individuals and their families. tDCS 
is a method for focal brain stimulation. tDCS is based 
on decades-old observations that neuronal ﬁring is 
modulated by low amplitude electrical direct current 
(DC). Speciﬁcally, when applied to the cerebral cortex, 
cathodal DC inhibits neuronal ﬁring [9, 10]. The 
mechanisms by which cathodal DC reduces neuronal 
ﬁring likely relate to hyper-polarization of the soma 
membrane which occurs when the apical dendrites 
neuron are oriented toward the cathode in a constant 
electric ﬁeld. The practical application of tDCS is 
simple: low amplitude DC is administered via scalp 
electrodes such that the cerebral cortex is exposed to 
cathodal DC beneath one of the electrodes, and the 
return (anodal) electrodes can be placed anywhere 
else on the body, or in more complex arrangements to 
minimize currents at any site. tDCS methods have also 
recently been adapted to rats for work with disease 
models [11-14]. Hundreds of tDCS trials have 
demonstrated the technique to be well tolerated and 
safe. Direct electrical current stimulation is presently 
FDA-approved for extracranial use, and FDA 
applications for cranial stimulation (tDCS) for 
management of mood disorder and chronic pain are in 
progress. tDCS units are also inexpensive and light-
weight. The electrical supply can be derived from 
conventional 9-volt batteries. The scalp electrodes can 
be fastened in seconds. tDCS can be combined easily 
with other therapies, such as those that may be 
required for resuscitation of an acutely-injured patient. 
tDCS is presently under investigation as a treatment 
for epilepsy, where excess cortical excitability is a 
prominent feature of the disease process, and where 
neuronal inhibition may be beneﬁcial. Thus for 
epi lepsy,  tDCS may offer  a pract ica l  non-
pharmacologic therapy for the large minority, 
approximately 35%, of patients whose seizure cannot 
be controlled by medication.
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